alt<unk>  is a premalignant condition, not a malignant one. Its malignant sequela, esophagogastric junctional adenocarcinoma, has a mortality rate of over 85%. The risk of developing esophageal adenocarcinoma in people who have<unk>  has been estimated to be 6–7 per 1000 person-years, but a cohort study of 11,028 patients from Denmark published in 2011 showed an incidence of only 1.2 per 1000 person-years (5.1 per 1000 person-years in patients with dysplasia, 1.0 per 1000 person-years in patients without dysplasia). The relative risk of esophageal adenocarcinoma is approximately 10 in those with<unk> , compared to the general population. Most patients with esophageal carcinoma survive less than one year.
Barrett's esophagus
Nutcracker esophagus
Herpes esophagitis
Zenker's diverticulum
Esophageal candidiasis
Lymphocytic esophagitis
Esophageal achalasia
Eosinophilic esophagitis